Autolus seeks $100M IPO to take next-gen CAR-Ts deep into the clinic

Autolus seeks $100M IPO to take next-gen CAR-Ts deep into the clinic

Source: 
Fierce Biotech
snippet: 

Autolus has filed to raise $100 million in a Nasdaq IPO. The British biotech wants the cash to bankroll clinical trials of a clutch of next-generation CAR-Ts designed to broaden the use of cell therapies while improving their safety and efficacy.